Clinical trial
IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage…
NCT00158678 · Groupe Oncologie Radiotherapie Tete et Cou, Other · Completed
Key facts
| NCT number | NCT00158678 |
|---|---|
| Title | IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC |
| Official title | Phase III Trial of Intensity-modulated Radiotherapy Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma |
| Lead sponsor | Groupe Oncologie Radiotherapie Tete et Cou, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Oral Cancer, Oropharynx Cancer, Hypopharynx Cancer |
| Intervention type | Drug, Procedure |
| Interventions | IMRT 75 Gy, Conventional radiotherapy 70 Gy, concomitant cisplatin |
| Enrollment | 310 |
| Start date | Sep 27, 2005 |
| Primary completion | Mar 22, 2020 |
| Completion | Mar 22, 2020 |
| First posted | Sep 12, 2005 |
| Last update posted | Apr 15, 2020 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: